Considerations for Selection and Use of Frontline Therapy in Mantle Cell Lymphoma
Shared insight on the optimal selection and use of frontline therapy for patients who present with mantle cell lymphoma.
EP: 1.An Overview of Mantle Cell Lymphoma and Frontline Therapy
Now Viewing
EP: 2.Considerations for Selection and Use of Frontline Therapy in Mantle Cell Lymphoma
EP: 3.Second-Line Therapy for MCL: Differentiating Available BTK Inhibitors
EP: 4.CAR T-cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma
EP: 5.Optimizing MCL Management: Sequencing and Combination Strategies
EP: 6.Clinical Pearls in the Management of Mantle Cell Lymphoma
EP: 7.Pathophysiology of Follicular Lymphoma and Frontline Therapy
EP: 8.Novel Therapies and Treatment Selection in Patients With Relapsed/Refractory FL
EP: 9.PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
EP: 10.Optimizing the Sequencing of Therapy in Follicular Lymphoma
EP: 11.Clinical Pearls in the Management of Follicular Lymphoma
EP: 12.Frontline Treatment Options for Marginal Zone Lymphoma
EP: 13.Novel Treatment Strategies for Relapsed/Refractory MZL
EP: 14.Clinical Pearls in the Management of Marginal Zone Lymphoma
Related Videos
Related Content
